Hypertension Evaluation Project III
| ISRCTN | ISRCTN53383289 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN53383289 |
| Protocol serial number | 3 |
| Sponsor | University of Cologne (Germany) |
| Funder | University of Cologne (Germany) - Koeln Fortune Program, Faculty of Medicine |
- Submission date
- 31/10/2007
- Registration date
- 06/11/2007
- Last edited
- 31/12/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Hans Wilhelm Hoepp
Scientific
Scientific
Kerpener Str. 62
Cologne
50937
Germany
| hw.hoepp@uni-koeln.de |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | Hypertension Evaluation Project III |
| Study acronym | HEP III |
| Study objectives | Innovative ways for dissemination of guidelines are superior to traditional ways. |
| Ethics approval(s) | All participants took part voluntarily and the interventions were optional therefore ethics approval was not necessary. |
| Health condition(s) or problem(s) studied | Hypertension |
| Intervention | 1. Guideline in print 2. Interactive guideline 3. Expert seminars 4. Control group The intervention groups were 3825 physicians for the expert seminars and always 1500 for the guideline in print, the interactive guideline and the control group. The medium follow-up time after intervention was approximately six months. |
| Intervention type | Other |
| Primary outcome measure(s) |
Difference in guideline awareness between trained physicians and the control group. |
| Key secondary outcome measure(s) |
Overall guideline awareness. |
| Completion date | 31/03/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 8325 |
| Total final enrolment | 3825 |
| Key inclusion criteria | Participants of HEP I-trial: In the HEP-I trial we explored the guideline awareness of 24899 German physicians, including all internists, cardiologists and 22% of general practitioners in a nationwide survey. The data is already published (see http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=11677375) |
| Key exclusion criteria | See inclusion criteria. |
| Date of first enrolment | 01/01/2004 |
| Date of final enrolment | 31/03/2005 |
Locations
Countries of recruitment
- Germany
Study participating centre
Kerpener Str. 62
Cologne
50937
Germany
50937
Germany
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 25/06/2008 | 31/12/2020 | Yes | No |
Editorial Notes
31/12/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.
